Preclinical support at every development milestone
Toxicology studies are used to characterize the toxicity profile of a drug by identifying its impact on functionality and / or organ structure. This includes assessment of the severity and reversibility of toxicity, as well as dose ranges and their relationship to exposure. Toxicology studies aid in determining if, and to what degree, the candidate compound’s toxicity is dose-dependent, species-specific, mechanism-related and/or related to the method of administration.
A candidate compound must be assessed in many different kinds of non-clinical toxicity study before it can be administered to the first human volunteer; even more toxicity studies are required thereafter before the candidate compound receives marketing authorisation.
Medicilon's state-of-the-art preclinical facilities hold full AAALAC accreditation. With advanced platforms and experienced scientists, Medicilon guarantees the utmost professionalism in drug efficacy and safety assessments services, adhering to global regulatory standards. Offering services from stand-alone preclinical studies to comprehensive IND-enabling packages, Medicilon provides flexible solutions to efficiently support biotech and pharmaceutical clients in reaching their developmental milestones.